Antibody for the treatment of myocardial infarction

The present invention relates to a method for treating MI or AMI in a subject in need thereof comprising a step of administering to said subject a therapeutically effective amount of an agent capable of depleting CD8 T cells. More particularly, this present invention relates to a method for treating acute myocardial infarction by reducing the size of necrosis and limiting the post ischemic left ventricular remodeling.

Keywords: Cardiovascular, Myocardial infarction, antibody, Cardio-Immunology
Patent Application number: null
Inventors:
null
Publications:
In progress

Reference:

BIO15275-T1

    Business Developper
    contact
    Aymeric Empereur
    Business Developer
    Patent filling date: 12-10-2015
    Rare disease: No
    Second indication: No

    You might also be interested in